Literature DB >> 26338321

Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation.

Jorge L Cueva Vargas1, Ingrid K Osswald2, Nicolas Unsain3, Mark R Aurousseau2, Philip A Barker3, Derek Bowie2, Adriana Di Polo4.   

Abstract

Loss of vision in glaucoma results from the selective death of retinal ganglion cells (RGCs). Tumor necrosis factor α (TNFα) signaling has been linked to RGC damage, however, the mechanism by which TNFα promotes neuronal death remains poorly defined. Using an in vivo rat glaucoma model, we show that TNFα is upregulated by Müller cells and microglia/macrophages soon after induction of ocular hypertension. Administration of XPro1595, a selective inhibitor of soluble TNFα, effectively protects RGC soma and axons. Using cobalt permeability assays, we further demonstrate that endogenous soluble TNFα triggers the upregulation of Ca(2+)-permeable AMPA receptor (CP-AMPAR) expression in RGCs of glaucomatous eyes. CP-AMPAR activation is not caused by defects in GluA2 subunit mRNA editing, but rather reflects selective downregulation of GluA2 in neurons exposed to elevated eye pressure. Intraocular administration of selective CP-AMPAR blockers promotes robust RGC survival supporting a critical role for non-NMDA glutamate receptors in neuronal death. Our study identifies glia-derived soluble TNFα as a major inducer of RGC death through activation of CP-AMPARs, thereby establishing a novel link between neuroinflammation and cell loss in glaucoma. SIGNIFICANCE STATEMENT: Tumor necrosis factor α (TNFα) has been implicated in retinal ganglion cell (RGC) death, but how TNFα exerts this effect is poorly understood. We report that ocular hypertension, a major risk factor in glaucoma, upregulates TNFα production by Müller cells and microglia. Inhibition of soluble TNFα using a dominant-negative strategy effectively promotes RGC survival. We find that TNFα stimulates the expression of calcium-permeable AMPA receptors (CP-AMPAR) in RGCs, a response that does not depend on abnormal GluA2 mRNA editing but on selective downregulation of the GluA2 subunit by these neurons. Consistent with this, CP-AMPAR blockers promote robust RGC survival supporting a critical role for non-NMDA glutamate receptors in glaucomatous damage. This study identifies a novel mechanism by which glia-derived soluble TNFα modulates neuronal death in glaucoma.
Copyright © 2015 the authors 0270-6474/15/3512088-15$15.00/0.

Entities:  

Keywords:  AMPA receptor; calcium; glaucoma; neuroinflammation; retinal ganglion cell; tumor necrosis factor

Mesh:

Substances:

Year:  2015        PMID: 26338321      PMCID: PMC6605307          DOI: 10.1523/JNEUROSCI.1273-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  97 in total

1.  Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons.

Authors:  M Passafaro; V Piëch; M Sheng
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

2.  Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype.

Authors:  S Q Liu; S G Cull-Candy
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

4.  Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

Authors:  Maria L Olleros; Reto Guler; Nadia Corazza; Dominique Vesin; Hans-Pietro Eugster; Gilles Marchal; Pierre Chavarot; Christoph Mueller; Irene Garcia
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  Control of synaptic strength by glial TNFalpha.

Authors:  Eric C Beattie; David Stellwagen; Wade Morishita; Jacqueline C Bresnahan; Byeong Keun Ha; Mark Von Zastrow; Michael S Beattie; Robert C Malenka
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

6.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

7.  Activated microglia in the human glaucomatous optic nerve head.

Authors:  L Yuan; A H Neufeld
Journal:  J Neurosci Res       Date:  2001-06-01       Impact factor: 4.164

8.  Drug-induced systemic lupus erythematosus associated with etanercept therapy.

Authors:  Najia Shakoor; Margaret Michalska; Charlotte A Harris; Joel A Block
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

9.  Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo.

Authors:  C Mueller; N Corazza; S Trachsel-Løseth; H P Eugster; M Bühler-Jungo; T Brunner; M A Imboden
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

View more
  48 in total

Review 1.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

Review 2.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

3.  Mechanisms of Channel Block in Calcium-Permeable AMPA Receptors.

Authors:  Edward C Twomey; Maria V Yelshanskaya; Alexander A Vassilevski; Alexander I Sobolevsky
Journal:  Neuron       Date:  2018-08-16       Impact factor: 17.173

4.  Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.

Authors:  Marius Chiasseu; Jorge L Cueva Vargas; Laurie Destroismaisons; Christine Vande Velde; Nicole Leclerc; Adriana Di Polo
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

5.  Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment.

Authors:  Mine Bariş; Gülgün Tezel
Journal:  Curr Ophthalmol Rep       Date:  2019-04-23

6.  Cell-type-specific binocular vision guides predation in mice.

Authors:  Keith P Johnson; Michael J Fitzpatrick; Lei Zhao; Bing Wang; Sean McCracken; Philip R Williams; Daniel Kerschensteiner
Journal:  Neuron       Date:  2021-03-29       Impact factor: 17.173

7.  Oxidative Stress and Hypoxia Modify Mitochondrial Homeostasis During Glaucoma.

Authors:  Assraa Hassan Jassim; Yan Fan; Nathaniel Pappenhagen; Nana Yaa Nsiah; Denise M Inman
Journal:  Antioxid Redox Signal       Date:  2021-04-29       Impact factor: 8.401

Review 8.  Parvalbumin interneuron vulnerability and brain disorders.

Authors:  Jacob B Ruden; Laura L Dugan; Christine Konradi
Journal:  Neuropsychopharmacology       Date:  2020-07-28       Impact factor: 7.853

Review 9.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

10.  The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissues associated with glaucoma pathogenesis.

Authors:  Chad A Sundberg; Monika Lakk; Sharan Paul; Karla P Figueroa; Daniel R Scoles; Stefan M Pulst; David Križaj
Journal:  J Comp Neurol       Date:  2021-08-18       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.